By uttu
July 16 (SeeNews) – U.S.-headquartered Alloy Therapeutics, a biotech firm focused on expanding access to drug discovery tools, said it has signed a memorandum of understanding with Serbia’s state-owned operator of the planned BIO4 Campus tech park in the capital of Belgrade to support the growth of Serbia’s biotech sector.
Read more here.